Healthcare

Request for TOC Request for Sample
BUY NOW

Global Whole Slide Imaging Market – Industry Trends and Forecast to 2031

Healthcare | Upcoming Report | Jul 2024 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60

Report Description

Global Whole Slide Imaging Market, By Technology (Scanners, IT Infrastructure, Viewer, and Image Management System), Application (Telepathology, Cytopathology, Immunohistochemistry, and Hematopathology), End User (Hospitals, Pharmaceutical and Biopharmaceutical Companies, Laboratories, Academic Institute, Research, and Others) – Industry Trends and Forecast to 2031.


 

Whole Slide Imaging Market Analysis and Size

In the field of pathology and diagnostics, whole slide imaging is revolutionizing how diseases, particularly cancers, are diagnosed. WSI allows pathologists to digitize entire glass slides, creating high-resolution images that can be analyzed on computer screens. This digital approach enhances diagnostic accuracy and efficiency by enabling advanced image analysis techniques and the use of artificial intelligence. Additionally, WSI facilitates remote diagnostics, allowing pathologists to access and evaluate slides from anywhere in the world, thus improving access to expert opinions and reducing diagnostic delays.

The global whole slide imaging market size was valued at USD 1.04 billion in 2023 and is projected to reach USD 3.39 billion by 2031, with a CAGR of 15.90% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Report Metric

Details

Forecast Period

2024-2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Technology (Scanners, IT Infrastructure, Viewer, and Image Management System), Application (Telepathology, Cytopathology, Immunohistochemistry, and Hematopathology), End User (Hospitals, Pharmaceutical and Biopharmaceutical Companies, Laboratories, Academic Institute, Research, and Others)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America

Market Players Covered

OLYMPUS CORPORATION (Japan), Leica Biosystems Nussloch GmbH (Germany), Hamamatsu Photonics K.K. (Japan), 3DHISTECH Ltd. (Hungary), Koninklijke Philips N.V. (Netherlands), Indica Labs, Inc. (U.S.), Inspirata, Inc. (U.S.), Nikon Instruments Inc. (Japan), Mikroscan Technologies, Inc. (U.S.), Visiopharm A/S (Denmark), PerkinElmer Inc. (U.S.), Akoya Biosciences, Inc. (U.S.), Siemens Healthineers AG (Germany), Hologic, Inc. (U.S.), Carl Zeiss AG (Germany)

Market Opportunities

  • Advancements in Digital Pathology
  • Growth in Research and Development

Market Definition

Whole slide imaging (WSI) is a process that involves scanning traditional glass microscope slides to create high-resolution digital images of the entire tissue sample. These digital slides can be viewed, analyzed, and shared on computer screens, enabling remote diagnosis, digital archiving, and advanced image analysis. Whole slide imaging is widely used in pathology for educational, clinical, and research purposes.

Whole Slide Imaging Market Dynamics

Drivers

  • Growing Supportive Government Policies

Government worldwide are increasingly recognizing the benefits of digital pathology and are implementing policies to promote its adoption. Initiatives include funding for healthcare technology upgrades, grants for research and development in digital pathology, and regulatory frameworks that encourage the use of digital tools in medical diagnostics. These policies aim to improve diagnostic accuracy, reduce healthcare costs, and enhance patient care. By providing financial incentives and regulatory support, governments are facilitating the widespread implementation of whole slide imaging technologies in medical institutions.

  • Rising Prevalence of Chronic Diseases

Rising chronic diseases demands for accurate and efficient diagnostic tools that can handle large volumes of tissue samples with high precision. WSI addresses these needs by digitizing entire pathology slides, allowing pathologists to analyze samples more comprehensively and accurately. This technology facilitates earlier detection, precise diagnosis, and personalized treatment planning, crucial in managing chronic diseases effectively. Moreover, WSI supports research efforts aimed at understanding disease mechanisms and developing new therapies, further driving its adoption in healthcare systems worldwide.

Opportunities

  • Advancements in Digital Pathology

Advancements in digital pathology include significant improvements in imaging technologies, such as higher resolution scanners and faster image processing capabilities, which enhance the quality and efficiency of slide digitization. Integration of artificial intelligence (AI) and machine learning algorithms further improves diagnostic accuracy by assisting pathologists in analyzing digital slides. Moreover, digital pathology enables seamless integration with electronic health records (EHRs) and laboratory information systems (LIS), streamlining workflow and enhancing data management. These technological advancements boost diagnostic capabilities and support remote consultations, telepathology, and collaborative research efforts, thereby driving the adoption of whole slide imaging across healthcare settings worldwide.

  • Growth in Research and Development

Whole slide imaging enables researchers to efficiently analyze large volumes of tissue samples with high-resolution digital images, facilitating more detailed and accurate investigations into diseases and treatments. This capability is crucial in pharmaceutical and biotechnology sectors for drug discovery, efficacy testing, and toxicology studies. Additionally, whole slide imaging supports collaborative research efforts by allowing seamless sharing and remote access to digital slides among researchers globally, enhancing productivity and accelerating scientific discoveries.

Restraints/Challenges

  • High Initial Investment

Whole slide imaging systems involve substantial costs for acquiring scanners, digital slide management software, and IT infrastructure capable of handling large image data. These upfront expenses can be prohibitive for smaller healthcare facilities, pathology labs, and research institutions, limiting their ability to adopt WSI technology. Moreover, ongoing maintenance and upgrade costs add to the financial burden.

  • Growing Management Challenges

Management challenges include establishing robust storage solutions capable of managing massive image files securely and efficiently. Additionally, integrating WSI systems with existing laboratory information systems (LIS) and electronic health records (EHR) can be technically demanding and costly. Training pathologists and laboratory personnel to effectively use WSI technology and ensuring compliance with data privacy regulations further complicate implementation.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Whole Slide Imaging Market Scope

The market is segmented on the basis of technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Scanners
  • IT Infrastructure
  • Viewer
  • Image Management System

Application

  • Telepathology
  • Cytopathology
  • Immunohistochemistry
  • Hematopathology

End User

  • Hospitals
  • Pharmaceutical and Biopharmaceutical Companies
  • Laboratories
  • Academic Institute
  • Research
  • Others

Whole Slide Imaging Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, technology, application and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.

Asia-Pacific dominates the market due to significant advancements in drug discovery research and growing awareness of the technology's benefits. Increased investment in healthcare infrastructure and the rising prevalence of chronic diseases also drive market growth. Additionally, government initiatives supporting digital pathology further bolster the adoption of whole slide imaging in the region.

North America is expected to experience substantial growth in the market due to increased government initiatives promoting the adoption of advanced technologies. This growth is further fueled by a rise in research and development activities across various industries. The region's emphasis on innovation and technological advancements is expected to drive significant market expansion during this period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Whole Slide Imaging Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

  • OLYMPUS CORPORATION (Japan)
  • Leica Biosystems Nussloch GmbH (Germany)
  • Hamamatsu Photonics K.K. (Japan)
  • 3DHISTECH Ltd. (Hungary)
  • Koninklijke Philips N.V. (Netherlands)
  • Indica Labs, Inc. (U.S.)
  • Inspirata, Inc. (U.S.)
  • Nikon Instruments Inc. (Japan)
  • Mikroscan Technologies, Inc. (U.S.)
  • Visiopharm A/S (Denmark)
  • PerkinElmer Inc. (U.S.)
  • Akoya Biosciences, Inc. (U.S.)
  • Siemens Healthineers AG (Germany)
  • Hologic, Inc. (U.S.)
  • Carl Zeiss AG (Germany)


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3200.00
  • 8000.00
  • 15000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19